"A new microneedle patch being developed by the Georgia Institute of Technology and the Centers for Disease Control and Prevention (CDC) could make it easier to vaccinate people against measles and other vaccine-preventable diseases.
Prior to administration of this vaccine, inform the individual, parent, guardian, or other responsible adult of the following:
- The potential benefits and risks of immunization with Prevnar 13 [see WARNINGS AND PRECAUTIONS and ADVERSE REACTIONS].
- The importance of completing the immunization series unless contraindicated.
- Any suspected adverse reactions should be reported to their healthcare professional.
Provide the Vaccine Information Statements, which are available free of charge at the Centers for Disease Control and Prevention (CDC) website (www.cdc.gov/vaccines).
This product's label may have been updated. For current full prescribing information, please visit www.pfizer.com.
Last reviewed on RxList: 11/16/2015
This monograph has been modified to include the generic and brand name in many instances.
Additional Prevnar 13 Information
Report Problems to the Food and Drug Administration
Find out what women really need.